HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis

被引：32
作者：
Blum, Arnon [1 ,2 ]
机构：
[1] Bar Ilan Univ, Baruch Padeh Poria Hosp, Dept Med, IL-15208 Lower Galilee, Israel
[2] Bar Ilan Univ, Fac Med, IL-15208 Lower Galilee, Israel
来源：
BIOFACTORS | 2014年 / 40卷 / 03期
关键词：
endothelial stem cells; atherosclerosis; inflammation; C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; IMPROVES CARDIAC-FUNCTION; E-DEFICIENT MICE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; FAMILIAL HYPERCHOLESTEROLEMIA; OXIDATIVE MODIFICATION;
D O I：
10.1002/biof.1157
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Statins have been shown to favorably affect the prognosis of patients with risk factors to atherosclerosis-both as a primary and a secondary prevention. The beneficial effects observed with statin therapy are not merely related to changes in lipid profile but also are due to a positive effect on vascular inflammation and on immune-modulation of T lymphocytes and endothelial progenitor stem cells (EPCs). This dual effect has been demonstrated mainly in clinical trials where a change in endothelial function was observed within hours, much earlier than the effects of statins on the lipid profile (weeks). Based on all the knowledge that we have today questions were raised as to the mechanistic pathways that may explain the process of atherosclerosis and through this pathway to find better solutions and therapies to prevent and fight atherosclerosis. Our review will focus on the new updates in the field of inflammation and stem cells in vascular biology-in relation with atherosclerosis. (C) 2014 BioFactors
引用
收藏
页码：295 / 302
页数：8
相关论文
共 97 条
[91]   Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease [J].
Vasa, M ;
Fichtlscherer, S ;
Adler, K ;
Aicher, A ;
Martin, H ;
Zeiher, AM ;
Dimmeler, S .
CIRCULATION, 2001, 103 (24) :2885-2890
[92]   Cholesterol, cholesterol lowering, and endothelial function [J].
Vogel, RA ;
Corretti, MC ;
Gellman, J .
PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 41 (02) :117-136
[93]   Statin therapy accelerates reendothelialization - A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells [J].
Walter, DH ;
Rittig, K ;
Bahlmann, FH ;
Kirchmair, R ;
Silver, M ;
Murayama, T ;
Nishimura, H ;
Losordo, DW ;
Asahara, T ;
Isner, JM .
CIRCULATION, 2002, 105 (25) :3017-3024
[94]   HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species [J].
Wassmann, S ;
Laufs, U ;
Bäumer, AT ;
Müller, K ;
Ahlbory, K ;
Linz, W ;
Itter, G ;
Rösen, R ;
Böhm, M ;
Nickenig, G .
HYPERTENSION, 2001, 37 (06) :1450-1457
[95]   Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease [J].
White, Harvey ;
Held, Claes ;
Stewart, Ralph ;
Watson, David ;
Harrington, Robert ;
Budaj, Andrzej ;
Steg, Ph. Gabriel ;
Cannon, Christopher P. ;
Krug-Gourley, Susan ;
Wittes, Janet ;
Trivedi, Trupti ;
Tarka, Elizabeth ;
Wallentin, Lars .
AMERICAN HEART JOURNAL, 2010, 160 (04) :655-U289
[96]   The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? [J].
Witztum, JL ;
Steinberg, D .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (3-4) :93-102
[97]   Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management [J].
Zanger, D ;
Yang, BK ;
Ardans, J ;
Waclawiw, MA ;
Csako, G ;
Wahl, LM ;
Cannon, RO .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1797-1802
12345678910